(Q44766117)

6 December 2017

Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure (English)

1 reference

6 December 2017

1 reference

chronic heart failure

1 reference

Katarzyna Hryniewicz

1

1 reference

6 December 2017

Ana Silvia Androne

series ordinal

2

1 reference

6 December 2017

Alhakam Hudaihed

series ordinal

3

1 reference

6 December 2017

Stuart D Katz

series ordinal

4

1 reference

6 December 2017

language of work or name

1 reference

1 December 2003

1 reference

Journal of Cardiac Failure

6 December 2017

1 reference

6 December 2017

9

1 reference

6 December 2017

6

1 reference

6 December 2017

464-468

1 reference

Wasting as independent risk factor for mortality in chronic heart failure

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Cachexia: time to receive more attention

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

1 reference

7 January 2021

Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

THE PATHOGENESIS OF CARDIAC CACHEXIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Reversal of catabolism by beta-blockade after severe burns

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

The role of leptin in human physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Catabolism in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Plasma leptin concentrations and energy expenditure in heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Hyperleptinaemia in chronic heart failure. Relationships with insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Nutritional abnormalities contributing to cachexia in chronic illness

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

The Nutrition Implications of Cardiac Cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Increased resting metabolic rate in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2803%2900582-7

7 January 2021

10.1016/S1071-9164(03)00582-7

Identifiers

DOI

1 reference

6 December 2017

1 reference